Prodrugs in genetic chemoradiotherapy.

Abstract:

:Improvements in the radiotherapeutic management of solid tumors through the concurrent use of gene therapy is a realistic possibility. Of the broad array of candidate genes that have been evaluated, those encoding prodrug-activating enzymes are particularly appealing since they directly complement ongoing clinical chemoradiation regimes. Gene-Directed Enzyme-Prodrug Therapy (GDEPT) only requires a fraction of the target cells to be genetically modified, providing that the resultant cytotoxic prodrug metabolites redistribute efficiently (the bystander effect). This transfer of cytotoxicity to neighboring non-targeted cancer cells is central to the success of any gene therapy strategy, irrespective of the therapeutic gene employed. In the context of genetic chemoradiotherapy, efficient prodrug metabolite diffusion will be a prerequisite for efficient radiosensitization. Some, but not all GDEPT approaches have been analysed in combination with radiotherapy. Examples of prodrugs of clinically established chemotherapeutic agents currently used in conjunction with radiotherapy include: 5-fluorocytosine (5FC), cyclophosphamide (CPA), irinotecan (CPT-11), gemcitabine (dFdC), capecitabine, mitomycin C (MMC) and AQ4N. Other GDEPT paradigms, such as ganciclovir (GCV) and Herpes Simplex thymidine kinase (HSV-tk), dinitrobenzamide (DNB) mustard or aziridinyl analogs and the E. coli nitroreductase (NTR), CMDA or ZP2767P with Pseudomonas aeruginosa carboxypeptidase G2 (CPG2), and indole-3-acetic acid (IAA) activated by horseradish peroxidase (HRP) have no clinically established chemotherapeutic counterpart. Each prodrug is discussed in this review in the context of GDEPT, with a particular attention to translational research and clinical utility in combination with radiotherapy.

journal_name

Curr Pharm Des

authors

Patterson AV,Saunders MP,Greco O

doi

10.2174/1381612033454117

subject

Has Abstract

pub_date

2003-01-01 00:00:00

pages

2131-54

issue

26

eissn

1381-6128

issn

1873-4286

journal_volume

9

pub_type

杂志文章,评审
  • Approaches to gastrointestinal cytoprotection: from isolated cells, via animal experiments to healthy human subjects and patients with different gastrointestinal disorders.

    abstract::Our clinical observations proved that the the duodenal ulcer in patients healed without any inhibition of gastric acid secretion (1965), and the healing rates of atropine vs cimetidine vs Carbenoxolone were equal and superior to that of placebo in randomized, prospective and multiclinical study of DU patients (1978). ...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章

    doi:10.2174/138161211796197016

    authors: Mózsik G,Szabó IL,Czimmer J

    更新日期:2011-01-01 00:00:00

  • Vitamins in Heart Failure: Friend or Enemy?

    abstract:BACKGROUND:The failing heart is characterized by a depleted metabolic energy reserve and the upregulation of several molecular mechanisms leading to cardiac hypertrophy, inflammation, fibrosis, angiogenesis, and apoptosis. Dietary or non-dietary supplementation of vitamins could potentially benefit energy balance. OBJ...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612823666170321094711

    authors: Georgiopoulos G,Chrysohoou C,Vogiatzi G,Magkas N,Bournelis I,Bampali S,Gruson D,Tousoulis D

    更新日期:2017-01-01 00:00:00

  • Obstacles and Opportunities for Cholinergic Drug Development in the Treatment of Cognitive Disorders.

    abstract::The frequency of neuropsychiatric disorders is greater than that of cancer, cardiovascular disease, and diabetes combined, and is growing at a faster rate than any other ailments in the United States or Europe. Despite a considerable need for the development of treatments for central nervous system disorders, pharmace...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612822666160127111453

    authors: Schroeder RA,Wecker L,Philpot RM

    更新日期:2016-01-01 00:00:00

  • Gamma-secretase as a pharmacological target in Alzheimer disease research: when, why and how?

    abstract::Alzheimer disease (AD) is characterized by excessive deposition of amyloid beta-peptides (Abeta peptides) in the form of senile plaques as well as neurofibrillary tangles (NFTs) in the brain. In the amyloidogenic pathway, the amyloid-beta precursor protein (APP) is cleaved by beta-secretase first, followed by gamma-se...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/138161206778792994

    authors: Ziani-Cherif C,Mostefa-Kara B,Brixi-Gormat FZ

    更新日期:2006-01-01 00:00:00

  • Clinical Review: Safety and Efficacy Comparison between Sulfonylureas and Dipeptidyl Peptidase-4 Inhibitors as Second-Line Therapies in Type 2 Diabetes Mellitus.

    abstract:BACKGROUND:According to the World Health Organization (WHO), diabetes mellitus is considered the 7th leading cause of death as of 2016, while almost half of all deaths related to high blood glucose occur before the age of 70. According to the 2019 American Diabetes Association's (ADA) guidelines, metformin is the first...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章

    doi:10.2174/1381612826666200408095310

    authors: Gillani SW,Moosvi AF

    更新日期:2020-01-01 00:00:00

  • From 2D to 3D--a New Dimension for Modelling the Effect of Natural Products on Human Tissue.

    abstract::Natural products, or their synthetic derivatives are a treasure trove to find potential candidates for novel drugs for human treatment. The selection of diamonds from the huge pile of worthless stone is a critical--and difficult--stage in the discovery pipeline. Of all the factors to be considered, perhaps the most im...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612821666151002114227

    authors: Wrzesinski K,Fey SJ

    更新日期:2015-01-01 00:00:00

  • The new antiepileptic drugs: pharmacological and clinical aspects.

    abstract::In recent years several new drugs (oxcarbazepine, lamotrigine, topiramate, gabapentin, zonisamide, tiagabine, fosphenytoin, vigabatrin and felbamate) have been added to the therapeutic armamentarium against epilepsy. Some of these represent structural modifications of pre-existing compounds, others were developed with...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612003400245

    authors: Gatti G,Bonomi I,Jannuzzi G,Perucca E

    更新日期:2000-05-01 00:00:00

  • Treating high density lipoprotein cholesterol (HDL-C): quantity versus quality.

    abstract::Low density lipoproteins (LDL) and high density lipoproteins (HDL) are independent risk factors for coronary heart disease (CHD); decreasing LDL-cholesterol (LDL-C) levels with statin therapy represents the primary goal in the management of cardiovascular disease. However, despite the efficacy of statins in reducing c...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/13816128113199990298

    authors: Pirillo A,Norata GD,Catapano AL

    更新日期:2013-01-01 00:00:00

  • Radix Stephaniae Tetrandrine: An Emerging Role for Management of Breast Cancer.

    abstract:BACKGROUND:Radix Stephaniae Tetrandrine (RST), known as FangJi (Pinyin name) in Chinese, is the dried root of Stephania tetrandra S.Moore, and has been prescribed in combination with other herbs to treat cardiovascular diseases and breast cancer in traditional Chinese medicine (TCM) clinical trials. OBJECTIVE:The aim ...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612826666200110143706

    authors: Guo Y,Chen B,Pei X,Zhang D

    更新日期:2020-01-01 00:00:00

  • Polyphenols, Antioxidants and the Sympathetic Nervous System.

    abstract:BACKGROUND:A high dietary intake of polyphenols has been associated with a reduced cardiovascular mortality, due to their antioxidant properties. However, growing evidence suggests that counteracting oxidative stress in cardiovascular disease might also reduce sympathetic nervous system overactivity. METHODS:This arti...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612823666171114170642

    authors: Bruno RM,Ghiadoni L

    更新日期:2018-01-01 00:00:00

  • Hypertension - Current Natural Strategies to Lower Blood Pressure.

    abstract::The prevalence of hypertension (HTN) worldwide is high and is constantly rising. HTN is considered to be a silent killer since often there are no obvious symptoms but long-term, HTN significantly increases the risk of coronary heart disease and cerebrovascular diseases. Those with diagnosed HTN or at high risk of its ...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612823666170215144649

    authors: Rysz J,Franczyk B,Banach M,Gluba-Brzozka A

    更新日期:2017-01-01 00:00:00

  • Gene therapy approaches for the selective killing of cancer cells.

    abstract::This review describes gene therapy strategies that take advantage of defective signal transduction pathways to selectively kill cancer cells without adversely affecting normal cells. The distinctive features of cancer cells currently exploited by gene therapy include mitosis, cell permissiveness to infection, specific...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612023393927

    authors: Westphal EM,Melchner Hv Hv

    更新日期:2002-01-01 00:00:00

  • The role of blood-brain barrier transporters in pathophysiology and pharmacotherapy of stroke.

    abstract::Cerebral ischemia is one of the major causes of disability worldwide. In cerebral ischemic stroke, occlusion of a major cerebral artery by an embolus or local thrombosis can result in transient or permanent reduction of cerebral blood flow to a portion of the brain, resulting in deprivation of glucose and oxygen. Sinc...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/13816128113199990465

    authors: Shah K,Abbruscato T

    更新日期:2014-01-01 00:00:00

  • Pine Bark Phenolic Extracts, Current Uses, and Potential Food Applications: A Review.

    abstract:PURPOSE:To summarize the main findings from research on food uses of Pine Bark Phenolic Extracts (PBPE), their origin, methods of extraction, composition, health effects, and incorporation into food products. METHODS:A narrative review of all the relevant papers known to the authors was conducted. RESULTS:PBPE are ma...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612826666200212113903

    authors: Dridi W,Bordenave N

    更新日期:2020-01-01 00:00:00

  • Safety Profile of the Newest Antiepileptic Drugs: A Curated Literature Review.

    abstract:BACKGROUND:Despite the introduction of new antiepileptic drugs (AEDs), the quality of life and therapeutic response for patients with epilepsy remain unsatisfactory. In addition, whilst several antiepileptic drugs (AEDs) have been approved and consequently marketed in recent years, little is known about their long-term...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612823666170809115429

    authors: Palleria C,Cozza G,Khengar R,Libri V,De Sarro G

    更新日期:2017-01-01 00:00:00

  • Marine-derived Polyaromatic Butenolides - Isolation, Synthesis and Biological Evaluations.

    abstract::Marine invertebrates, especially tunicates, are a lucrative resource for the discovery of new lead compounds for the development of clinically utilized drugs. This review describes the isolation, synthesis and biological activities of several classes of marine-derived butenolide natural products, namely rubrolides and...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章

    doi:10.2174/1381612826666200518110617

    authors: Bracegirdle J,Keyzers RA

    更新日期:2020-01-01 00:00:00

  • Mechanisms of action of anesthetics for the modulation of perioperative thrombosis: evidence for immune mechanisms from basic and clinical studies.

    abstract::Thrombotic events occurring in either arteries or veins are the primary causes of fatal perioperative cardiovascular events. Risk factors for deep vein thrombosis, several of which are evidently associated with specific surgical procedures, are quite different from those for arterial thrombosis (e.g., aging or atheros...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612820666140204102044

    authors: Azma T,Tuluc F,Ito T,Aoyama-Mani C,Kawahito S,Kinoshita H

    更新日期:2014-01-01 00:00:00

  • Therapeutic applications of human heme oxygenase gene transfer and gene therapy.

    abstract::The search for methods to control physiological levels of carbon monoxide (CO), a vasoactive molecule, and bilibrubin, an antioxidant, have improved our understanding of the protective role of heme oxygenase (HO) against oxidative injury. HO activity can assist other antioxidant systems in diminishing the overall prod...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612033453758

    authors: Abraham NG

    更新日期:2003-01-01 00:00:00

  • Microdialysis in neurointensive care.

    abstract::Microdialysis is a technique for sampling the chemistry of the interstitial fluid of tissues and organs in animal and man. It is minimally invasive and simple to perform in a clinical setting. Although microdialysis samples essentially all small molecular substances present in the interstitial fluid the use of microdi...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612043384105

    authors: Ungerstedt U,Rostami E

    更新日期:2004-01-01 00:00:00

  • Safety and efficacy of ximelagatran: meta-analysis of the controlled randomized trials for the prophylaxis or treatment of venous thromboembolism.

    abstract:BACKGROUND:Ximelagatran has been approved in Europe for VTE prophylaxis in orthopedic surgery at fixed doses and without laboratory monitoring. Aim of the study was to evaluate safety and efficacy of ximelagatran in a meta-analysis of prophylaxis and/or treatment randomized controlled trials. METHODS:Absolute risk of ...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,meta分析

    doi:10.2174/138161205774580534

    authors: Iorio A,Guercini F,Ferrante F,Nenci GG

    更新日期:2005-01-01 00:00:00

  • Vasopressin secretion control: central neural pathways, neurotransmitters and effects of drugs.

    abstract::Vasopressin (AVP) secretion and release are regulated by a number of central nervous system sites that receive peripheral signals from the osmoreceptors and baroreceptors. Aim of this paper is to review anatomical pathways and neurotransmitters involved as well as drugs affecting AVP secretion. ...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/138161212802651607

    authors: Iovino M,Guastamacchia E,Giagulli VA,Licchelli B,Triggiani V

    更新日期:2012-01-01 00:00:00

  • Review of QSAR models for enzyme classes of drug targets: Theoretical background and applications in parasites, hosts, and other organisms.

    abstract::The number of protein 3D structures without function annotation in Protein Data Bank (PDB) has been steadily increased. Many of these proteins are relevant for Pharmaceutical Design because they may be enzymes of different classes that could become drug targets. This fact has led in turn to an increment of demand for ...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/138161210792389207

    authors: Concu R,Podda G,Ubeira FM,González-Díaz H

    更新日期:2010-01-01 00:00:00

  • The implications of human stem cell differentiation to endothelial cell via fluid shear stress in cardiovascular regenerative medicine: a review.

    abstract::Stem cell therapy heralds a new chapter in cardiovascular regenerative medicine. Cardiovascular implants are often used in both surgery and interventional cardiology. Cardiovascular stents are utilized in percutaneous coronary interventions (PCI), and are classified as either bare metal stents (BMS) or drug-eluting st...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/138161210794455058

    authors: Tan A,Sumpio BE,Lee S,Seifalian AM

    更新日期:2010-01-01 00:00:00

  • Biohybrid Membrane Systems and Bioreactors as Tools for In Vitro Drug Testing.

    abstract::In drug development, in vitro human model systems are absolutely essential prior to the clinical trials, considering the increasing number of chemical compounds in need of testing, and, keeping in mind that animals cannot predict all the adverse human health effects and reactions, due to the species-specific differenc...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612822666161025155616

    authors: Salerno S,Bartolo L

    更新日期:2017-01-01 00:00:00

  • Development of novel cardiovascular therapeutics from small regulatory RNA molecules--an outline of key requirements.

    abstract::Understanding of the roles of RNAs within the cell has changed and expanded dramatically during the past few years. Based on fundamentally new insights it is now increasingly possible to employ RNAs as highly valuable tools in molecular biology and medicine. At present, the most important therapeutic strategies are ba...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/138161210791792813

    authors: Poller W,Fechner H

    更新日期:2010-01-01 00:00:00

  • Subcutaneous Immunoglobulins: A Promising Alternative for Immunomodulation?

    abstract::Cumulative recent evidence from clinical trials, observational studies and case reports has shown that subcutaneous administration of immunoglobulin (SCIg) exerts similar immunomodulatory capacity than intravenous immunoglobulin (IVIg) in autoimmune neurological diseases. Besides the beneficial clinical effects, the p...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612822666160831103806

    authors: Sanchez-Ramon S,Corbi AL,Fidalgo AG,Dominguez-Soto A

    更新日期:2016-01-01 00:00:00

  • Viral proteases as targets for drug design.

    abstract::In order to productively infect a host, viruses must enter the cell and force host cell replication mechanisms to produce new infectious virus particles. The success of this process unfortunately results in disease progression and, in the case of infection with many viral species, may cause mortality. The discoveries ...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章

    doi:10.2174/1381612811319060013

    authors: Skoreński M,Sieńczyk M

    更新日期:2013-01-01 00:00:00

  • From Fangs to Pharmacology: The Future of Snakebite Envenoming Therapy.

    abstract::The snake is the symbol of medicine due to its association with Asclepius, the Greek God of medicine, and so with good reasons. More than 725 species of venomous snakes have toxins specifically evolved to exert potent bioactivity in prey or victims, and snakebites constitute a public health hazard of high impact in As...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612822666160623073438

    authors: Laustsen AH,Engmark M,Milbo C,Johannesen J,Lomonte B,Gutiérrez JM,Lohse B

    更新日期:2016-01-01 00:00:00

  • DSPE-PEG: a distinctive component in drug delivery system.

    abstract::1, 2-Distearoyl-sn-glycero-3-phosphoethanolamine-Poly(ethylene glycol) (DSPE- PEG) is a widely used phospholipids-polymer conjugate in drug delivery applications. It is a biocompatible, biodegradable and amphiphilic material which can also be functionalized with various biomolecules for specific functions. With the em...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612821666150115144003

    authors: Che J,Okeke CI,Hu ZB,Xu J

    更新日期:2015-01-01 00:00:00

  • Ghrelin as a potential anti-obesity target.

    abstract::In order to develop an effective pharmacological treatment for obesity, an endogenous factor that promotes a positive energy balance by increasing appetite and decreasing fat oxidation could represent the drug target scientists have been looking for. The recently discovered gastric endocrine agent ghrelin, which appea...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612033454748

    authors: Horvath TL,Castañeda T,Tang-Christensen M,Pagotto U,Tschöp MH

    更新日期:2003-01-01 00:00:00